Arcellx

Rendering of an immune cell
Biotech

ASH: Gilead-Arcellx data build CAR-T's case in advanced myeloma

Arcellx's new data on a Gilead-partnered CAR-T show durable results and best-in-class potential for advanced multiple myeloma, analysts said.
Gabrielle Masson Nov 5, 2024 3:08pm
Graphic image of a body shaded in black with drawn clouds around their head Dark blue background

NIH to invest another $515M over 4 years for long COVID research

Feb 15, 2024 10:57am
market busy fresh fruit buy crowd

Gilead hands Arcellx $285M to expand BCMA cell therapy deal

Nov 15, 2023 10:00am
Go sign green light

FDA lifts hold on Gilead's CAR-T as Arcellx sheds light on death

Aug 15, 2023 8:32am
FDA stop sign

FDA puts Gilead's $225M BCMA CAR-T on hold over patient death

Jun 20, 2023 6:15am
ASH

ASH: BCMA battle heats up as Gracell dazzles with 100% ORR in MM

Dec 12, 2022 5:55am